Company profile
BioNTech SE
NASDAQ:BNTXBiotechnology: Biological Products (No Diagnostic Substances)
Drug pipeline (6)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| Trastuzumab Pamirtecan | phase3 | — | 1 | active |
| AUTOGENE CEVUMERAN | phase2 | — | 1 | active |
| BNT-152 MRNA | phase1 | — | 1 | no active trials |
| BNT-153 MRNA | phase1 | — | 1 | no active trials |
| MVT-1075 | phase1 | — | 1 | terminated |
Revenue is the latest reported period from SEC filings. A combination product's amount appears on each of its constituent assets, so those rows are not additive.
Clinical trials (83)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05988203 | phase1_2 | completed | 2023-09-21 | 2025-08-25 | BioNTech SE | A Clinical Study Investigating the Safety and Immune Responses After Immunization With Investigational Monkeypox Vaccines |
| NCT06940804 | phase2 | withdrawn | 2025-07-01 | 2042-06-01 | BioNTech SE | A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm |
| NCT06340568 | phase3 | recruiting | 2025-06-10 | 2028-03-01 | BioNTech SE | A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer |
| NCT04625205 | phase1 | terminated | 2020-12-01 | 2025-03-26 | BioNTech US Inc. | A Clinical Study of the Safety and Activity of the Investigational Cell Therapy NEO-PTC-01 in Patients With Advanced Melanoma |
| NCT04503278 | phase1 | active_not_recruiting | 2020-09-16 | 2028-08-01 | BioNTech Cell & Gene Therapies GmbH | A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors |
FDA applications (1)
| Application | Type | Applicant | Products | |||
|---|---|---|---|---|---|---|
| BLA 125742 | BLA | BioNTech Manufacturing GmbH | ||||
Loading… | ||||||